James H. Sabry, Executive Chairman at CYTOKINETICS INC (CYTK), sold 7,000 shares at $5.04 ($35K) on 2007-10-01, disclosed to the SEC on 2007-10-02.
Scheduled sale ($35k) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 2,000 | $10K | 28.4% |
| 2 | $5.01 | 900 | $5K | 12.8% |
| 3 | $5.02 | 764 | $4K | 10.9% |
| 4 | $5.03 | 1,300 | $7K | 18.6% |
| 5 | $5.04 | 800 | $4K | 11.5% |
| 6 | $5.05 | 563 |
| $3K |
| 8.1% |
| 7 | $5.06 | 100 | $506 | 1.4% |
| 8 | $5.10 | 173 | $882 | 2.5% |
| 9 | $5.12 | 400 | $2K | 5.8% |
| Total | $5.03 avg | 7,000 | $35K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |